Event Title
Real World Hematologic Toxicities in Patients > 70 versus < 69 with ER Positive Metastatic Breast Cancer on CDK 4/6 Inhibitors: Single Institution Retrospective Study
Facility
NS/LIJ
Department
Division of Hematology/Oncology, Department of Medicine
Status
Fellow
Category
Clinical Science Research
Start Date
3-6-2020 12:00 AM
COinS
Jun 3rd, 12:00 AM
Real World Hematologic Toxicities in Patients > 70 versus < 69 with ER Positive Metastatic Breast Cancer on CDK 4/6 Inhibitors: Single Institution Retrospective Study